We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 938.40 | 940.00 | 941.60 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMNMC
RNS Number : 8645R
NMC Health Plc
14 December 2016
NMC Health plc
REVISED REMUNERATION POLICY - PUBLICATION OF CIRCULAR
London, 14 December 2016: NMC Health plc (NMC or the Company) (LSE: NMC), the leading integrated private healthcare provider operating across the United Arab Emirates, and one of the top global providers of fertility treatment, announces circulation of a notice to convene a General Meeting to consider the adoption of a new remuneration policy with related explanatory circular (the Circular).
The General Meeting (the GM) will be held on Thursday 29 December 2016 at 12:10 pm at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD. The Notice of Meeting with related explanatory circular and the associated Form of Proxy have today been published and posted to shareholders. A copy of the Circular and the accompanying Form of Proxy have also been submitted to the National Storage Mechanism and will shortly be available for inspection at www.Morningstar.co.uk/uk/NSM. In addition, the Circular will be available to view on the Company's website http://www.nmchealth.com/shareholder-information/ and available for inspection at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD.
Contacts:
Investors: NMC Simon Watkins, Group Company Secretary +44 (0)20 3205 7313 Media: FTI Consulting, London Matthew Cole +44 (0)20 3727 1101 FTI Consulting, Gulf Shane Dolan +971 (0)4 437 2100
About NMC
NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. In addition, NMC acquired a 51% shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation (IVF) services. NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2m patients in 2015. The group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Health plc group reported revenues of US$880.9m in 2015.
In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. NMC Health plc is a constituent of the FTSE 250 Index.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUSRSRNKAUAAA
(END) Dow Jones Newswires
December 14, 2016 09:11 ET (14:11 GMT)
1 Year Nmc Health Chart |
1 Month Nmc Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
